Mechanisms Underlying Persistent Lentivirus Replication in Follicular T Cells
滤泡 T 细胞中慢病毒持续复制的机制
基本信息
- 批准号:9393264
- 负责人:
- 金额:$ 34.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-12-01 至 2018-11-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAlpha CellAntibodiesAntibody FormationAntigensB-LymphocytesBLR1 geneBiological AssayCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCD8B1 geneCell MaturationCellsCessation of lifeChronicChronic DiseaseComplexCytotoxic T-LymphocytesDevelopmentFollicular Dendritic CellsFosteringFrequenciesHIVHIV-1Helper-Inducer T-LymphocyteHumanImmunologic Deficiency SyndromesImpairmentIn SituIn Situ HybridizationIn VitroIndividualInfectionLabelLeadLentivirus InfectionsLocationLymphocyte FunctionLymphoid TissueMacacaMacaca mulattaMeasuresMinorityModelingPhenotypePredispositionReporterRoleSIVSeriesSignal TransductionStaining methodStainsStructure of germinal center of lymph nodeSubfamily lentivirinaeT-LymphocyteTestingTimeTissuesVaccinesVirionVirusVirus Replicationadaptive immunitycytokineexperimental studyhuman tissuein vitro Assayin vivopermissivenesspublic health relevancetargeted treatmentviral RNA
项目摘要
DESCRIPTION (provided by applicant): In both chronic HIV-1 and SIV infection, virus replication is concentrated in lymphoid tissues in follicular CD4+ T cells, which are 30 to 40 times more likely to be productively infected than extrafollicular CD4+ T cells. Reasons why lentiviruses are preferentially replicated by follicular CD4+ T cells and why virus-specific cytotoxic T lymphocytes (CTL) cannot suppress replication in these cells are not understood. Virus replication is not concentrated in B cell follicles in acute SIV infection, suggesting that te follicular concentration of virus may be related to adaptive immunity. T follicular helper cells (TFH) are a specialized subset of antigen-specific cells that migrate into B cell follicles where they interact with B cells and follicular dendritic cells (FDC) to promote B cell maturation and antibody production. We hypothesize that virus replication is concentrated within TFH in chronic HIV-1 and SIV infection due to 1) increased intrinsic susceptibility of TFH to productive lentiviru infection, 2) their location in germinal centers (GC) adjacent to antibody-virion complexes on FDC, and 3) numerical and functional deficiencies of follicular CTL. These hypotheses will be tested through a series of experiments both in vitro and in vivo using lymphoid tissues from humans and rhesus macaques. In Aim 1, we will establish whether human and macaque TFH are intrinsically more susceptible to productive lentivirus infection than other CD4+ T cells through in vitro experimental infections with GFP reporter viruses. In aim 2, we will determine the distribution and phenotype of productively infected T cells in vivo in both chronic and acute lentivirus infection by in situ tissue analyses as well as measuring viral RNA in sorted subsets of
cells. In Aim 3 we will investigate the hypothesis that numerical and/or functional deficiencies in
follicular CTL contribute to the propagation of HIV-1 within B cell follicles using in situ studies in vitro assays of follicular CTL function, and CD8 depletion of rhesus macaques in vivo. In the context of all aims, we will evaluate the impact of T follicular regulatory cells (TFR), on HIV-1 replication and CTL function. Collectively, these studies will provide a wealth of new information on the cells that foster HIV-1 replication in B cell follicles and factors in the follicular milieuthat may promote or impair lentivirus replication. A better understanding of the mechanisms that underlie permissiveness of follicular CD4+ T cells to lentiviruses is vital to development of a protective vaccine or a functional cure for HIV-1.
描述(由申请人提供):在慢性HIV-1和SIV感染中,病毒复制集中在滤泡CD4+ T细胞中的淋巴样组织中,滤泡CD4+ T细胞比滤泡外CD4+ T细胞更容易被有效感染30至40倍。为什么慢病毒优先被滤泡CD4+ T细胞复制,以及为什么病毒特异性细胞毒性T淋巴细胞(CTL)不能抑制这些细胞中的复制,原因尚不清楚。急性SIV感染时,病毒复制不集中在B细胞滤泡中,提示滤泡中病毒的浓度可能与适应性免疫有关。T滤泡辅助细胞(TFH)是抗原特异性细胞的一个特殊子集,它们迁移到B细胞滤泡中,在那里它们与B细胞和滤泡树突状细胞(FDC)相互作用,促进B细胞成熟和抗体产生。我们假设,在慢性HIV-1和SIV感染中,病毒复制集中在TFH内,这是因为1)TFH对生产性慢病毒感染的内在易感性增加,2)TFH位于FDC上邻近抗体-病毒粒子复合物的生发中心(GC),以及3)滤泡CTL的数量和功能缺陷。这些假设将通过使用人类和恒河猴淋巴组织的一系列体外和体内实验进行验证。在Aim 1中,我们将通过GFP报告病毒的体外实验感染,确定人类和猕猴的TFH是否比其他CD4+ T细胞更容易受到生产性慢病毒感染。在目标2中,我们将通过原位组织分析以及在分类的慢病毒亚群中测量病毒RNA,确定慢性和急性慢病毒感染中体内生产性感染T细胞的分布和表型
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Elizabeth Connick其他文献
Elizabeth Connick的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Elizabeth Connick', 18)}}的其他基金
Using Sleep Health to Optimize Smoking Cessation Treatment Response in HIV-Positive Adults
利用睡眠健康来优化艾滋病毒阳性成人的戒烟治疗反应
- 批准号:
10203906 - 财政年份:2020
- 资助金额:
$ 34.11万 - 项目类别:
Using Sleep Health to Optimize Smoking Cessation Treatment Response in HIV-Positive Adults
利用睡眠健康来优化艾滋病毒阳性成人的戒烟治疗反应
- 批准号:
10754698 - 财政年份:2020
- 资助金额:
$ 34.11万 - 项目类别:
Using Sleep Health to Optimize Smoking Cessation Treatment Response in HIV-Positive Adults
利用睡眠健康来优化艾滋病毒阳性成人的戒烟治疗反应
- 批准号:
10618603 - 财政年份:2020
- 资助金额:
$ 34.11万 - 项目类别:
Using Sleep Health to Optimize Smoking Cessation Treatment Response in HIV-Positive Adults
利用睡眠健康来优化艾滋病毒阳性成人的戒烟治疗反应
- 批准号:
10404545 - 财政年份:2020
- 资助金额:
$ 34.11万 - 项目类别:
Using Sleep Health to Optimize Smoking Cessation Treatment Response in HIV-Positive Adults
利用睡眠健康来优化艾滋病毒阳性成人的戒烟治疗反应
- 批准号:
10633175 - 财政年份:2020
- 资助金额:
$ 34.11万 - 项目类别:
Using Sleep Health to Optimize Smoking Cessation Treatment Response in HIV-Positive Adults
利用睡眠健康来优化艾滋病毒阳性成人的戒烟治疗反应
- 批准号:
10013743 - 财政年份:2020
- 资助金额:
$ 34.11万 - 项目类别:
Mechanisms Underlying Persistent Lentivirus Replication in Follicular T Cells
滤泡 T 细胞中慢病毒持续复制的机制
- 批准号:
9184519 - 财政年份:2012
- 资助金额:
$ 34.11万 - 项目类别:
Mechanisms Underlying Persistent Lentivirus Replication in Follicular T Cells
滤泡 T 细胞中慢病毒持续复制的机制
- 批准号:
8587460 - 财政年份:2012
- 资助金额:
$ 34.11万 - 项目类别:
Mechanisms Underlying Persistent Lentivirus Replication in Follicular T Cells
滤泡 T 细胞中慢病毒持续复制的机制
- 批准号:
8466682 - 财政年份:2012
- 资助金额:
$ 34.11万 - 项目类别:
相似海外基金
The Role of Arginine Transport on Pancreatic Alpha Cell Proliferation and Function
精氨酸转运对胰腺α细胞增殖和功能的作用
- 批准号:
10678248 - 财政年份:2023
- 资助金额:
$ 34.11万 - 项目类别:
Alpha cell-derived Extracellular Vesicles and Maternal Insulin Production
α细胞来源的细胞外囊泡和母体胰岛素的产生
- 批准号:
10681939 - 财政年份:2023
- 资助金额:
$ 34.11万 - 项目类别:
Targeting alpha-cell GPCRs to stimulate glucagon and counter hypoglycemia
靶向 α 细胞 GPCR 刺激胰高血糖素并对抗低血糖
- 批准号:
10427574 - 财政年份:2022
- 资助金额:
$ 34.11万 - 项目类别:
Arginine regulation of alpha cell proliferation and function
精氨酸调节α细胞增殖和功能
- 批准号:
10609909 - 财政年份:2022
- 资助金额:
$ 34.11万 - 项目类别:
Regulation of alpha-cell glucagon secretion by mitochondrial anaplerosis-cataplerosis
线粒体回补-回补对α细胞胰高血糖素分泌的调节
- 批准号:
10607392 - 财政年份:2022
- 资助金额:
$ 34.11万 - 项目类别:
Targeting alpha-cell GPCRs to stimulate glucagon and counter hypoglycemia
靶向 α 细胞 GPCR 刺激胰高血糖素并对抗低血糖
- 批准号:
10675646 - 财政年份:2022
- 资助金额:
$ 34.11万 - 项目类别:
Elucidating alpha cell defects in human type 1 diabetes using precision cut pancreas slice-on-a-chip coupled with high spatio-temporal microscopy
使用精密切割的胰腺切片结合高时空显微镜阐明人类 1 型糖尿病的 α 细胞缺陷
- 批准号:
457552 - 财政年份:2021
- 资助金额:
$ 34.11万 - 项目类别:
Studentship Programs
Defining alpha-cell proglucagon processing for type 2 diabetes treatment
定义 2 型糖尿病治疗的 α 细胞胰高血糖素原加工过程
- 批准号:
10331361 - 财政年份:2020
- 资助金额:
$ 34.11万 - 项目类别:
In vivo systems to discover mechanisms regulating human islet alpha cell function
体内系统发现调节人类胰岛α细胞功能的机制
- 批准号:
10623306 - 财政年份:2020
- 资助金额:
$ 34.11万 - 项目类别:
Defining alpha-cell PC1/3 expression regulation for type 2 diabetes
定义 2 型糖尿病的 α 细胞 PC1/3 表达调控
- 批准号:
10376866 - 财政年份:2020
- 资助金额:
$ 34.11万 - 项目类别: